1
|
Shah BM, Modi P, Trivedi P. Recent Investigation on Synthetic ‘Triazoles’ Scaffold as Potential Pharmacological Agents: A Comprehensive Survey. CHEMISTRY AFRICA 2023. [DOI: 10.1007/s42250-023-00617-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
2
|
Kumar A, Singh AK, Singh H, Vijayan V, Kumar D, Naik J, Thareja S, Yadav JP, Pathak P, Grishina M, Verma A, Khalilullah H, Jaremko M, Emwas AH, Kumar P. Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals (Basel) 2023; 16:299. [PMID: 37259442 PMCID: PMC9965678 DOI: 10.3390/ph16020299] [Citation(s) in RCA: 23] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 01/26/2023] [Accepted: 01/28/2023] [Indexed: 07/30/2023] Open
Abstract
Cancer is one of the major healthcare challenges across the globe. Several anticancer drugs are available on the market but they either lack specificity or have poor safety, severe side effects, and suffer from resistance. So, there is a dire need to develop safer and target-specific anticancer drugs. More than 85% of all physiologically active pharmaceuticals are heterocycles or contain at least one heteroatom. Nitrogen heterocycles constituting the most common heterocyclic framework. In this study, we have compiled the FDA approved heterocyclic drugs with nitrogen atoms and their pharmacological properties. Moreover, we have reported nitrogen containing heterocycles, including pyrimidine, quinolone, carbazole, pyridine, imidazole, benzimidazole, triazole, β-lactam, indole, pyrazole, quinazoline, quinoxaline, isatin, pyrrolo-benzodiazepines, and pyrido[2,3-d]pyrimidines, which are used in the treatment of different types of cancer, concurrently covering the biochemical mechanisms of action and cellular targets.
Collapse
Affiliation(s)
- Adarsh Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Ankit Kumar Singh
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Harshwardhan Singh
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Veena Vijayan
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Deepak Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Jashwanth Naik
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Suresh Thareja
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Jagat Pal Yadav
- Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, Rama University, Kanpur 209217, India
| | - Prateek Pathak
- Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, 454008 Chelyabinsk, Russia
| | - Maria Grishina
- Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, 454008 Chelyabinsk, Russia
| | - Amita Verma
- Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India
| | - Habibullah Khalilullah
- Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unayzah 51911, Saudi Arabia
| | - Mariusz Jaremko
- Smart-Health Initiative and Red Sea Research Center, Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia
| | - Abdul-Hamid Emwas
- Core Labs, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia
| | - Pradeep Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| |
Collapse
|
3
|
Abd El Salam HA, Fathy U, Zayed EM, El Shehry MF, Ahmed E.Gouda A. Design, Synthesis, Cytotoxic Activity and Molecular Docking Studies of Naphthyl Pyrazolyl Thiazole Derivatives as Anticancer Agents. ChemistrySelect 2023. [DOI: 10.1002/slct.202203956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Affiliation(s)
- Hayam A. Abd El Salam
- Green Chemistry Department National Research Centre, Dokki-Giza-Egypt-P.O.12622 Cairo Egypt
| | - Usama Fathy
- Applied Organic Chemistry Department National Research Centre, Dokki-Giza-Egypt-P.O.12622 Cairo Egypt Corresponding Author
| | - Ehab M. Zayed
- Green Chemistry Department National Research Centre, Dokki-Giza-Egypt-P.O.12622 Cairo Egypt
| | - Mohamed F. El Shehry
- Pesticide Chemistry Department National Research Centre, Dokki-Giza-Egypt-P.O.12622 Cairo Egypt
| | | |
Collapse
|
4
|
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids. Pharmaceuticals (Basel) 2022; 15:ph15091071. [PMID: 36145292 PMCID: PMC9500727 DOI: 10.3390/ph15091071] [Citation(s) in RCA: 34] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 08/19/2022] [Accepted: 08/22/2022] [Indexed: 11/16/2022] Open
Abstract
Cancer is a complex disease, and its treatment is a big challenge, with variable efficacy of conventional anticancer drugs. A two-drug cocktail hybrid approach is a potential strategy in recent drug discovery that involves the combination of two drug pharmacophores into a single molecule. The hybrid molecule acts through distinct modes of action on several targets at a given time with more efficacy and less susceptibility to resistance. Thus, there is a huge scope for using hybrid compounds to tackle the present difficulties in cancer medicine. Recent work has applied this technique to uncover some interesting molecules with substantial anticancer properties. In this study, we report data on numerous promising hybrid anti-proliferative/anti-tumor agents developed over the previous 10 years (2011–2021). It includes quinazoline, indole, carbazole, pyrimidine, quinoline, quinone, imidazole, selenium, platinum, hydroxamic acid, ferrocene, curcumin, triazole, benzimidazole, isatin, pyrrolo benzodiazepine (PBD), chalcone, coumarin, nitrogen mustard, pyrazole, and pyridine-based anticancer hybrids produced via molecular hybridization techniques. Overall, this review offers a clear indication of the potential benefits of merging pharmacophoric subunits from multiple different known chemical prototypes to produce more potent and precise hybrid compounds. This provides valuable knowledge for researchers working on complex diseases such as cancer.
Collapse
|
5
|
Ullah I, Ilyas M, Omer M, Alamzeb M, Adnan, Sohail M. Fluorinated triazoles as privileged potential candidates in drug development—focusing on their biological and pharmaceutical properties. Front Chem 2022; 10:926723. [PMID: 36017163 PMCID: PMC9395585 DOI: 10.3389/fchem.2022.926723] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2022] [Accepted: 06/30/2022] [Indexed: 11/21/2022] Open
Abstract
Fluorinated heterocycles have attracted extensive attention not only in organic synthesis but also in pharmaceutical and medicinal sciences due to their enhanced biological activities than their non-fluorinated counterparts. Triazole is a simple five-membered heterocycle with three nitrogen atoms found in both natural and synthetic molecules that impart a broad spectrum of biological properties including but not limited to anticancer, antiproliferative, inhibitory, antiviral, antibacterial, antifungal, antiallergic, and antioxidant properties. In addition, incorporation of fluorine into triazole and its derivatives has been reported to enhance their pharmacological activity, making them promising drug candidates. This mini-review explores the current developments of backbone-fluorinated triazoles and functionalized fluorinated triazoles with established biological activities and pharmacological properties.
Collapse
|
6
|
Synthesis of Some 2-Substituted-5-(Benzothiazol-2-yl)-1H-Benzimidazole Derivatives and Investigation of Their Antiproliferative Effects. Pharm Chem J 2022. [DOI: 10.1007/s11094-022-02658-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
7
|
Dawbaa S, Evren AE, Cantürk Z, Yurttaş L. Synthesis of new thiazole derivatives and evaluation of their antimicrobial and cytotoxic activities. PHOSPHORUS SULFUR 2021. [DOI: 10.1080/10426507.2021.1972299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Sam Dawbaa
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskişehir, Turkey
- Department of Pharmacy, Faculty of Medicine and Health Sciences, Thamar University, Dhamar, Yemen
| | - Asaf Evrim Evren
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskişehir, Turkey
- Vocational School of Health Services, Bilecik Şeyh Edebali University, Bilecik, Turkey
| | - Zerrin Cantürk
- Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Anadolu University, Eskişehir, Turkey
| | - Leyla Yurttaş
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskişehir, Turkey
| |
Collapse
|
8
|
Pawar S, Kumar K, Gupta MK, Rawal RK. Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents. Anticancer Agents Med Chem 2021; 21:1379-1402. [PMID: 32723259 DOI: 10.2174/1871520620666200728133017] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2020] [Revised: 04/30/2020] [Accepted: 05/23/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Cancer is second leading disease after cardiovascular disease. Presently, Chemotherapy, Radiotherapy and use of chemicals are some treatments available these days. Thiazole and its hybrid compounds extensively used scaffolds in drug designing and development of novel anticancer agents due to their wide pharmacological profiles. Fused thiazole scaffold containing drugs are available in market as a promising group of anticancer agents. METHODS The detailed study has been done using different database that focused on potent thiazole hybrid compounds with anticancer activity. The literature included in this review is focused on novel fused thiazole derivatives exhibiting anticancer potency in last decade. RESULTS Literature suggested that thiazoles and its fused and linked congener serve excellent pharmacological profile as an anticancer agent. Various synthetic strategies for fused thiazole are also summarized in this article. Novel thiazole and its fused congener showed anticancer activity against various cancer cell lines. INTERPRETATION Thiazole is a promising scaffold reported in literature with broad range of biological activities. This article covers the thiazole compounds fused with other carbocyclic/heterocycle including benzene, imidazole, pyridine, pyrimidine, quinoline, phenothiazine, thiopyrano, steroids, pyrrole etc. with anticancer activity from last decades. Several inhibitors for breast cancer, colon cancer, melanoma cancer, ovarian cancer, tubulin cancer etc. were reported in this review. Thus, this review will definitely aid to develop a lead for the new selective anticancer agents in future.
Collapse
Affiliation(s)
- Swati Pawar
- Department of Chemistry, Maharishi Markandeshwar (Deemed to be University), Mullana-133207, Ambala, Haryana, India
| | - Kapil Kumar
- School of Pharmacy and Technology Management, SVKM's NMIMS, Hyderabad, Telangana-509301, India
| | - Manish K Gupta
- SGT College of Pharmacy, SGT University, Gurugram-Badli Road, Gurugram-122505, Haryana, India
| | - Ravindra K Rawal
- Department of Chemistry, Maharishi Markandeshwar (Deemed to be University), Mullana-133207, Ambala, Haryana, India
| |
Collapse
|
9
|
Almehmadi MA, Aljuhani A, Alraqa SY, Ali I, Rezki N, Aouad MR, Hagar M. Design, synthesis, DNA binding, modeling, anticancer studies and DFT calculations of Schiff bases tethering benzothiazole-1,2,3-triazole conjugates. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2020.129148] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
10
|
Hanikoglu A, Ozben H, Hanikoglu F, Ozben T. Hybrid Compounds & Oxidative Stress Induced Apoptosis in Cancer Therapy. Curr Med Chem 2020; 27:2118-2132. [PMID: 30027838 DOI: 10.2174/0929867325666180719145819] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2018] [Revised: 06/04/2018] [Accepted: 06/29/2018] [Indexed: 12/16/2022]
Abstract
Elevated Reactive Oxygen Species (ROS) generated by the conventional cancer therapies and the endogenous production of ROS have been observed in various types of cancers. In contrast to the harmful effects of oxidative stress in different pathologies other than cancer, ROS can speed anti-tumorigenic signaling and cause apoptosis of tumor cells via oxidative stress as demonstrated in several studies. The primary actions of antioxidants in cells are to provide a redox balance between reduction-oxidation reactions. Antioxidants in tumor cells can scavenge excess ROS, causing resistance to ROS induced apoptosis. Various chemotherapeutic drugs, in their clinical use, have evoked drug resistance and serious side effects. Consequently, drugs having single-targets are not able to provide an effective cancer therapy. Recently, developed hybrid anticancer drugs promise great therapeutic advantages due to their capacity to overcome the limitations encountered with conventional chemotherapeutic agents. Hybrid compounds have advantages in comparison to the single cancer drugs which have usually low solubility, adverse side effects, and drug resistance. This review addresses two important treatments strategies in cancer therapy: oxidative stress induced apoptosis and hybrid anticancer drugs.
Collapse
Affiliation(s)
- Aysegul Hanikoglu
- Department of Biochemistry, Faculty of Medicine, Akdeniz University, 07070 Antalya, Turkey
| | - Hakan Ozben
- Department of Orthopaedics and Traumatology, Hand and Microsurgery Unit, Koc University School of Medicine, Istanbul, Turkey
| | - Ferhat Hanikoglu
- Faculty of Pharmacy, Department of Biochemistry, Biruni University, Istanbul, Turkey
| | - Tomris Ozben
- Department of Biochemistry, Faculty of Medicine, Akdeniz University, 07070 Antalya, Turkey
| |
Collapse
|
11
|
Synthesis, cytotoxicity of some pyrazoles and pyrazolo[1,5-a]pyrimidines bearing benzothiazole moiety and investigation of their mechanism of action. Bioorg Chem 2020; 102:104053. [PMID: 32673889 DOI: 10.1016/j.bioorg.2020.104053] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2020] [Revised: 06/01/2020] [Accepted: 06/26/2020] [Indexed: 02/07/2023]
Abstract
A novel series of pyrazoles and pyrazolo[1,5-a]pyrimidines bearing benzothiazole moiety were designed and synthesized. Chemical structures were confirmed by spectral data and elemental analyses. Nine compounds were selected and screened for their cytotoxic activity at the National Cancer Institute (NCI), USA against 60 cancer cell lines in a single dose assay. Compounds 4 and 5 exerted the most potent growth inhibitory activity against most cancer cell lines with growth inhibition (GI%) ranges from 44.86% to 84.59% and 31.20% to 52.36%, respectively. Consequently, they were further investigated through IC50 determination using five dose MTT colorimetric assay against three sensitive cell lines, leukemia CCRF-CEM, non-small cell lung cancer HOP-92 and liver cancer Hep-G2. Compound 4 exhibited potent cytotoxic activity against the three tested cell lines with IC50 16.34, 3.45 and 7.79 μM, respectively representing half potency, 3.5 folds potency and nearly equipotent to roscovitine. To investigate its mechanism of action, cell cycle analysis of compound 4 was conducted and showed that it induced cell cycle arrest at G2/M phase and apoptosis in HOP-92 cells. In correlation with the previous results, caspase-3 activation was tested and illustrated elevation in its concentration by nearly 14 folds than control. Besides, enzyme inhibition assay of compound 4 was evaluated towards two common antitumor targets namely KDM1 and CDK1 showing significant inhibitory activity with IC50 0.096 and 0.078 μM, respectively.
Collapse
|
12
|
Appalanaidu K, Dadmal TL, Patil SM, Jagadeesh Babu N, Laxmikanth Rao J, Kumbhare RM. An Efficient One‐Shot Metal‐Free Electrophilic Fluorination of 2‐Iminothiazolidine‐4‐one. ChemistrySelect 2020. [DOI: 10.1002/slct.202000189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Killari Appalanaidu
- Fluoro AgrochemicalsDivision CSIR-Indian Institute of Chemical Technology, Tarnaka Hyderabad 500607 India
| | - Tulshiram L. Dadmal
- Department of Chemistry Government of Maharashtra's, IsmailYusuf College, Jogeshwari (E) Mumbai 400060 India
| | - Suvarna M. Patil
- Fluoro AgrochemicalsDivision CSIR-Indian Institute of Chemical Technology, Tarnaka Hyderabad 500607 India
| | - N. Jagadeesh Babu
- InstitutionLaboratory of X-ray Crystallography CSIR-Indian Institute of Chemical Technology Hyderabad 500607 India
| | - J. Laxmikanth Rao
- Dept. Of Catalysis and fine chemical CSIR-Indian Institute of Chemical Technology Hyderabad 500607 India
| | - Ravindra M. Kumbhare
- Fluoro AgrochemicalsDivision CSIR-Indian Institute of Chemical Technology, Tarnaka Hyderabad 500607 India
| |
Collapse
|
13
|
Bakkolla MG, Taduri AK, Bhoomireddy RD. A simple and facile synthesis of novel 1,2,3‐triazole substituted pyrimidine derivatives. J Heterocycl Chem 2020. [DOI: 10.1002/jhet.3964] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Mahesh Goud Bakkolla
- Department of ChemistryJawaharlal Nehru Technological University Hyderabad, College of Engineering Hyderabad Telangana India
| | - Ashok Kumar Taduri
- Department of ChemistryJawaharlal Nehru Technological University Hyderabad, College of Engineering Hyderabad Telangana India
| | - Rama Devi Bhoomireddy
- Department of ChemistryJawaharlal Nehru Technological University Hyderabad, College of Engineering Hyderabad Telangana India
| |
Collapse
|
14
|
Mashayekh K, Shiri P. An Overview of Recent Advances in the Applications of Click Chemistry in the Synthesis of Bioconjugates with Anticancer Activities. ChemistrySelect 2019. [DOI: 10.1002/slct.201902362] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Koroush Mashayekh
- Medicinal Plants and Drugs Research InstituteShahid Beheshti University, Tehran Iran
| | - Pezhman Shiri
- Department of ChemistryShiraz University, Shiraz Iran
| |
Collapse
|
15
|
Jain A, Piplani P. Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review. Mini Rev Med Chem 2019; 19:1298-1368. [DOI: 10.2174/1389557519666190312162601] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2018] [Revised: 02/28/2019] [Accepted: 03/06/2019] [Indexed: 12/20/2022]
Abstract
:
Triazole is a valuable platform in medicinal chemistry, possessing assorted pharmacological
properties, which could play a major role in the common mechanisms associated with various disorders
like cancer, infections, inflammation, convulsions, oxidative stress and neurodegeneration. Structural
modification of this scaffold could be helpful in the generation of new therapeutically useful
agents. Although research endeavors are moving towards the growth of synthetic analogs of triazole,
there is still a lot of scope to achieve drug discovery break-through in this area. Upcoming therapeutic
prospective of this moiety has captured the attention of medicinal chemists to synthesize novel triazole
derivatives. The authors amalgamated the chemistry, synthetic strategies and detailed pharmacological
activities of the triazole nucleus in the present review. Information regarding the marketed triazole derivatives
has also been incorporated. The objective of the review is to provide insights to designing and
synthesizing novel triazole derivatives with advanced and unexplored pharmacological implications.
Collapse
Affiliation(s)
- Ankit Jain
- Department of Pharmaceutical Chemistry, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh- 160014, India
| | - Poonam Piplani
- Department of Pharmaceutical Chemistry, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh- 160014, India
| |
Collapse
|
16
|
Xu Z, Zhao SJ, Liu Y. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. Eur J Med Chem 2019; 183:111700. [PMID: 31546197 DOI: 10.1016/j.ejmech.2019.111700] [Citation(s) in RCA: 249] [Impact Index Per Article: 49.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 09/08/2019] [Accepted: 09/12/2019] [Indexed: 12/15/2022]
Abstract
Anticancer agents are critical for the cancer treatment, but side effects and the drug resistance associated with the currently used anticancer agents create an urgent need to explore novel drugs with low side effects and high efficacy. 1,2,3-Triazole is privileged building block in the discovery of new anticancer agents, and some of its derivatives have already been applied in clinics or under clinical trials for fighting against cancers. Hybrid molecules occupy an important position in cancer control, and hybridization of 1,2,3-triazole framework with other anticancer pharmacophores may provide valuable therapeutic intervention for the treatment of cancer, especially drug-resistant cancer. This review emphasizes the recent advances in 1,2,3-triazole-containing hybrids with anticancer potential, covering articles published between 2015 and 2019, and the structure-activity relationships, together with mechanisms of action are also discussed.
Collapse
Affiliation(s)
- Zhi Xu
- Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, PR China.
| | - Shi-Jia Zhao
- Wuhan University of Science and Technology, Wuhan, PR China
| | - Yi Liu
- Wuhan University of Science and Technology, Wuhan, PR China.
| |
Collapse
|
17
|
Hassan AY, Husseiny EM. Synthesis and Anticancer Evaluation of Some Novel Thiophene, Thieno[3,2‐
d
]pyrimidine, Thieno[3,2‐
b
]pyridine, and Thieno[3,2‐
e
][1,4]oxazepine Derivatives Containing Benzothiazole Moiety. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3629] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Aisha Y. Hassan
- Department of Organic Chemistry, Faculty of Science (Girls)Al‐Azhar University Cairo Egypt
| | - Ebtehal M. Husseiny
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls)Al‐Azhar University Cairo Egypt
| |
Collapse
|
18
|
Hassan AY, Sarg MT, Hussein EM. Design, Synthesis, and Anticancer Activity of Novel Benzothiazole Analogues. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3524] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Aisha Y. Hassan
- Department of Chemistry, Faculty of Science (Girls) Al‐Azhar University Cairo Egypt
| | - Marwa T. Sarg
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls) Al‐Azhar University Cairo Egypt
| | - Ebtehal M. Hussein
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls) Al‐Azhar University Cairo Egypt
| |
Collapse
|
19
|
Evren AE, Yurttas L, Ekselli B, Akalin-Ciftci G. Synthesis and biological evaluation of 5-methyl-4-phenyl thiazole derivatives as anticancer agents. PHOSPHORUS SULFUR 2019. [DOI: 10.1080/10426507.2018.1550642] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Asaf E. Evren
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskişehir, Turkey
| | - Leyla Yurttas
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskişehir, Turkey
| | - Büşra Ekselli
- Faculty of Pharmacy, Department of Biochemistry, Anadolu University, Eskişehir, Turkey
| | - Gülşen Akalin-Ciftci
- Faculty of Pharmacy, Department of Biochemistry, Anadolu University, Eskişehir, Turkey
| |
Collapse
|
20
|
Narva S, Chitti S, Amaroju S, Goud S, Alvala M, Bhattacharjee D, Jain N, Kondapalli Venkata Gowri CS. Design, Synthesis, and Biological Evaluation of 2-(4-Aminophenyl)benzothiazole Analogues as Antiproliferative Agents. J Heterocycl Chem 2018. [DOI: 10.1002/jhet.3427] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Suresh Narva
- Department of Chemistry; Birla Institute of Technology and Science; Pilani, Hyderabad Campus, Jawahar Nagar Hyderabad 500078 Telangana India
| | - Surendar Chitti
- Department of Chemistry; Birla Institute of Technology and Science; Pilani, Hyderabad Campus, Jawahar Nagar Hyderabad 500078 Telangana India
| | - Suresh Amaroju
- Department of Chemistry; Birla Institute of Technology and Science; Pilani, Hyderabad Campus, Jawahar Nagar Hyderabad 500078 Telangana India
| | - Sridhar Goud
- National Institute of Pharmaceutical Education and Research-Hyderabad; Hyderabad 500037 Telangana India
| | - Mallika Alvala
- National Institute of Pharmaceutical Education and Research-Hyderabad; Hyderabad 500037 Telangana India
| | - Debanjan Bhattacharjee
- Centre for Chemical Biology; CSIR-Indian Institute of Chemical Technology; Tarnaka Hyderabad 500007 Telangana India
| | - Nishant Jain
- Centre for Chemical Biology; CSIR-Indian Institute of Chemical Technology; Tarnaka Hyderabad 500007 Telangana India
| | | |
Collapse
|
21
|
Design, synthesis and evaluation of novel hybrids between 4-anilinoquinazolines and substituted triazoles as potent cytotoxic agents. Bioorg Med Chem Lett 2018; 28:3741-3747. [DOI: 10.1016/j.bmcl.2018.10.016] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2018] [Revised: 10/09/2018] [Accepted: 10/10/2018] [Indexed: 01/08/2023]
|
22
|
Aouad MR, Soliman MA, Alharbi MO, Bardaweel SK, Sahu PK, Ali AA, Messali M, Rezki N, Al-Soud YA. Design, Synthesis and Anticancer Screening of Novel Benzothiazole-Piperazine-1,2,3-Triazole Hybrids. Molecules 2018; 23:molecules23112788. [PMID: 30373247 PMCID: PMC6278665 DOI: 10.3390/molecules23112788] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2018] [Revised: 10/24/2018] [Accepted: 10/26/2018] [Indexed: 02/07/2023] Open
Abstract
A library of novel regioselective 1,4-di and 1,4,5-trisubstituted-1,2,3-triazole based benzothiazole-piperazine conjugates were designed and synthesized using the click synthesis approach in the presence and absence of the Cu(I) catalyst. Some of these 1,2,3-triazole hybrids possess in their structures different heterocyclic scaffold including 1,2,4-triazole, benzothiazole, isatin and/or benzimidazole. The newly designed 1,2,3-triazole hybrids were assessed for their antiproliferative inhibition potency against four selected human cancer cell lines (MCF7, T47D, HCT116 and Caco2). The majority of the synthesized compounds demonstrated moderate to potent activity against all the cancer cell lines examined. Further, we have established a structure activity relationship with respect to the in silico analysis of ADME (adsorption, distribution, metabolism and excretion) analysis and found good agreement with in vitro activity.
Collapse
Affiliation(s)
- Mohamed R Aouad
- Department of Chemistry, Faculty of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi Arabia.
| | - Moataz A Soliman
- Department of Chemistry, Faculty of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi Arabia.
| | - Muath O Alharbi
- Department of Chemistry, Faculty of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi Arabia.
| | - Sanaa K Bardaweel
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman 11942, Jordan.
| | - Pramod K Sahu
- School of Study in Chemistry, Jiwaji University, Gwalior 474011, India.
| | - Adeeb A Ali
- Department of Chemistry, Faculty of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi Arabia.
| | - Mouslim Messali
- Department of Chemistry, Faculty of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi Arabia.
| | - Nadjet Rezki
- Department of Chemistry, Faculty of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi Arabia.
- Department of Chemistry, Faculty of Sciences, University of Sciences and Technology Mohamed Boudiaf, Laboratoire de Chimie et Electrochimie des Complexes Metalliques (LCECM) USTO-MB, P.O. Box 1505, El M'nouar, Oran 31000, Algeria.
| | - Yaseen A Al-Soud
- Faculty of Science, Al al-Bayt University, Al-Mafraq 25113, Jordan.
| |
Collapse
|
23
|
An investigation onto the molecular structure of 5-chloro-3-(2-(4-ethylpiperazine-1-il)-2-oxoethyl)benzo[d]thiazole-2(3H)-on drug molecule before and after atmospheric pressure plasma treatment. J Mol Struct 2018. [DOI: 10.1016/j.molstruc.2018.01.052] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
24
|
Bakherad M, Rezaeimanesh F, Nasr-Isfahani H. Copper-Catalyzed Click Synthesis of Novel 1,2,3-Triazole-Linked Pyrimidines. ChemistrySelect 2018. [DOI: 10.1002/slct.201703088] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Mohammad Bakherad
- Faculty of Chemistry; Shahrood University of Technology; Shahrood 3619995161 Iran
| | - Fatemeh Rezaeimanesh
- Faculty of Chemistry; Shahrood University of Technology; Shahrood 3619995161 Iran
| | | |
Collapse
|
25
|
Liu J, Ming B, Gong GH, Wang D, Bao GL, Yu LJ. Current research on anti-breast cancer synthetic compounds. RSC Adv 2018. [DOI: 10.1039/c7ra12912b] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
Breast cancer (BC) is the most common cancer for females and its incidence tends to increase year by year.
Collapse
Affiliation(s)
- Jia Liu
- Medicinal Chemistry and Pharmacology Institute
- Inner Mongolia University for Nationalities
- Tongliao
- People's Republic of China
- Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System
| | - Bian Ming
- Medicinal Chemistry and Pharmacology Institute
- Inner Mongolia University for Nationalities
- Tongliao
- People's Republic of China
- Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System
| | - Guo-Hua Gong
- First Clinical Medical of Inner Mongolia University for Nationalities
- Tongliao
- People's Republic of China
| | - Di Wang
- Medicinal Chemistry and Pharmacology Institute
- Inner Mongolia University for Nationalities
- Tongliao
- People's Republic of China
- Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System
| | - Gui-Lan Bao
- Medicinal Chemistry and Pharmacology Institute
- Inner Mongolia University for Nationalities
- Tongliao
- People's Republic of China
- Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System
| | - Li-Jun Yu
- Medicinal Chemistry and Pharmacology Institute
- Inner Mongolia University for Nationalities
- Tongliao
- People's Republic of China
- Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System
| |
Collapse
|
26
|
Dadmal TL, Katre SD, Mandewale MC, Kumbhare RM. Contemporary progress in the synthesis and reactions of 2-aminobenzothiazole: a review. NEW J CHEM 2018. [DOI: 10.1039/c7nj03776g] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Various protocols for the synthesis and reactions of 2-aminobenzothiazole.
Collapse
Affiliation(s)
- Tulshiram L. Dadmal
- Department of Chemistry
- Government of Maharashtra's
- Ismail Yusuf College
- Mumbai 400060
- India
| | - Sangita D. Katre
- Department of Chemistry
- Chhotabhai Javerbhai Patel College
- Gondia 441911
- India
| | - Mustapha C. Mandewale
- Department of Chemistry
- Government of Maharashtra's
- Ismail Yusuf College
- Mumbai 400060
- India
| | - Ravindra M. Kumbhare
- Fluoroorganics Division
- Indian Institute of Chemical Technology
- Hyderabad 500607
- India
| |
Collapse
|
27
|
Dadmal TL, Appalanaidu K, Kumbhare RM, Mondal T, Ramaiah MJ, Bhadra MP. Synthesis and biological evaluation of triazole and isoxazole-tagged benzothiazole/benzoxazole derivatives as potent cytotoxic agents. NEW J CHEM 2018. [DOI: 10.1039/c8nj01249k] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Cancer is a major health problem and the most upsetting disease in humans, leading to death in both developed and developing countries.
Collapse
Affiliation(s)
- Tulshiram L. Dadmal
- Fluoroorganic Division
- CSIR-Indian Institute of Chemical Technology
- Hyderabad 500007
- India
- Government of Maharashtra's
| | - K. Appalanaidu
- Fluoroorganic Division
- CSIR-Indian Institute of Chemical Technology
- Hyderabad 500007
- India
| | - Ravindra M. Kumbhare
- Fluoroorganic Division
- CSIR-Indian Institute of Chemical Technology
- Hyderabad 500007
- India
| | - Tanmoy Mondal
- Centre for Chemical Biology
- CSIR-Indian Institute of Chemical Technology
- Hyderabad
- India
| | - M. Janaki Ramaiah
- Centre for Chemical Biology
- CSIR-Indian Institute of Chemical Technology
- Hyderabad
- India
- School of Chemical and Biotechnology
| | - Manika Pal Bhadra
- Centre for Chemical Biology
- CSIR-Indian Institute of Chemical Technology
- Hyderabad
- India
| |
Collapse
|
28
|
Lauder K, Toscani A, Scalacci N, Castagnolo D. Synthesis and Reactivity of Propargylamines in Organic Chemistry. Chem Rev 2017; 117:14091-14200. [PMID: 29166000 DOI: 10.1021/acs.chemrev.7b00343] [Citation(s) in RCA: 290] [Impact Index Per Article: 41.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Propargylamines are a versatile class of compounds which find broad application in many fields of chemistry. This review aims to describe the different strategies developed so far for the synthesis of propargylamines and their derivatives as well as to highlight their reactivity and use as building blocks in the synthesis of chemically relevant organic compounds. In the first part of the review, the different synthetic approaches to synthesize propargylamines, such as A3 couplings and C-H functionalization of alkynes, have been described and organized on the basis of the catalysts employed in the syntheses. Both racemic and enantioselective approaches have been reported. In the second part, an overview of the transformations of propargylamines into heterocyclic compounds such as pyrroles, pyridines, thiazoles, and oxazoles, as well as other relevant organic derivatives, is presented.
Collapse
Affiliation(s)
- Kate Lauder
- School of Cancer and Pharmaceutical Sciences, King's College London , Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Anita Toscani
- School of Cancer and Pharmaceutical Sciences, King's College London , Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Nicolò Scalacci
- School of Cancer and Pharmaceutical Sciences, King's College London , Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Daniele Castagnolo
- School of Cancer and Pharmaceutical Sciences, King's College London , Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| |
Collapse
|
29
|
Recent advances (2015-2016) in anticancer hybrids. Eur J Med Chem 2017; 142:179-212. [PMID: 28760313 DOI: 10.1016/j.ejmech.2017.07.033] [Citation(s) in RCA: 182] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2017] [Revised: 07/13/2017] [Accepted: 07/18/2017] [Indexed: 12/26/2022]
Abstract
In spite of the development of a large number of novel anticancer drugs over the years, Cancer remains as a prominent cause of death, worldwide. Numerous drugs that are currently in clinical practice have developed multidrug resistance along with fatal side effects. Therefore, the utilization of single-target therapy is incapable of providing an effective control on the malignant process. Molecular hybridization, involving a combination of two or more pharmacophores of bioactive scaffolds to generate a single molecular architecture with improved affinity and activity, in comparison to their parent molecules, has emerged as a promising strategy in recent drug discovery research. Hybrid anticancer drugs are of great therapeutic interests since they can potentially overcome most of the pharmacokinetic drawbacks encountered with conventional anticancer drugs. Strategically, the design of anticancer drugs involved the blending or linking of an anticancer drug with another anticancer drug or a carrier molecule which can efficiently target cancer cells with improved biological potential. Major advantages of hybrid anticancer drugs involved increased specificity, better patient compliance, and lower side effects along with reduction in chemo-resistance. The successful utilization of this technique in design and synthesis of novel anticancer hybrids has been well illustrated and documented in the literature. The purpose of the present review article will be to provide an emphasis on the recent developments (2015-16) in anticancer hybrids with insights into their structure-activity relationship (SAR) and mechanism of action.
Collapse
|
30
|
Song P, Cui F, Li N, Xin J, Ma Q, Meng X, Wang C, Cao Q, Gu Y, Ke Y, Zhang Q, Liu H. Synthesis, Cytotoxic Activity Evaluation of Novel 1,2,3-Triazole Linked Quinazoline Derivatives. CHINESE J CHEM 2017. [DOI: 10.1002/cjoc.201700005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Panpan Song
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Fei Cui
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Na Li
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Jingchao Xin
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qisheng Ma
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Xiangchuan Meng
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Chaojie Wang
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qinpo Cao
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Yifei Gu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Yu Ke
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qiurong Zhang
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Hongmin Liu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| |
Collapse
|
31
|
Synthesis and biological evaluation of novel 2-imino-4-thiazolidinone derivatives as potent anti-cancer agents. Bioorg Med Chem Lett 2016; 26:5361-5368. [DOI: 10.1016/j.bmcl.2016.08.013] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2016] [Revised: 07/14/2016] [Accepted: 08/06/2016] [Indexed: 12/18/2022]
|
32
|
Kumbhare RM, Dadmal TL, Kumar D, Ramaiah MJ, Kota A, Chowdhury D, Appalanaidu K, Rao YK, Hyder S, Devi TA, Bhadra MP. Fluorinated thiazolidinols cause cell death in A549 lung cancer cells via PI3K/AKT/mTOR and MAPK/ERK signalling pathways. MEDCHEMCOMM 2016. [DOI: 10.1039/c5md00603a] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Fluorinated thiazolidinols cause A549 lung cancer cell death by acting via PI3K/Akt/mTOR and MEK/ERK pathways.
Collapse
Affiliation(s)
| | - Tulshiram L. Dadmal
- Fluoroorganic Division
- Indian Institute of Chemical Technology
- Hyderabad
- India
- Government of Maharashtra's
| | - Dinesh Kumar
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad
- India
| | - M. Janaki Ramaiah
- School of Chemical and Biotechnology
- Sastra University
- Thanjavur-613402
- India
| | - Anudeep Kota
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad
- India
| | - Debabrata Chowdhury
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad
- India
| | - K. Appalanaidu
- Fluoroorganic Division
- Indian Institute of Chemical Technology
- Hyderabad
- India
| | - Y. Khageswara Rao
- Fluoroorganic Division
- Indian Institute of Chemical Technology
- Hyderabad
- India
| | - Sayyad Hyder
- Fluoroorganic Division
- Indian Institute of Chemical Technology
- Hyderabad
- India
| | - T. Anjana Devi
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad
- India
| | - Manika Pal Bhadra
- Centre for Chemical Biology
- Indian Institute of Chemical Technology
- Hyderabad
- India
| |
Collapse
|